Topography and risk factors of amyloid-related imaging abnormality: real-world data from 168 aducanumab-treated patients at a private clinic in South Korea.
Yoon S, Ahn J, Kim S, Kim K, Kim SY, An SK, Na DG, Kim YJ, Kwak K, Seo SW, Na DL
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.